Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

August 2, 2024

Primary Completion Date

February 29, 2032

Study Completion Date

February 29, 2032

Conditions
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
Interventions
GENETIC

AAV2-hAQP1

Administration of a prespecified concentration of AAV2-hAQP1 via Stensen's duct to each parotid gland

Trial Locations (8)

14215

Erie County Medical Center, Buffalo

15212

Alleghany General Hospital, Pittsburgh

28209

Atrium Health, Charlotte

33176

Miami Cancer Institute at Baptist Health South Florida, Miami

52242

University of Iowa, Iowa City

65212

University of Missouri, Columbia

85234

Banner MD Anderson Cancer Center, Gilbert

P3E 5J1

Shirley and Jim Fielding Northeast Cancer Centre - Health Sciences North, Greater Sudbury

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MeiraGTx, LLC

INDUSTRY